Arizona couple Michael and Julie Carroll have lost a combined 177 lbs. on a GLP-1 weight loss drug. 'It gave me my ...

The obesity medication Zepbound can be used on-label to treat obstructive sleep apnea in adults with obesity, the FDA ...

The FDA approved a new drug treatment for obstructive sleep apnea that improves the condition through weight loss. Sleep ...

FDA has approved the first prescription drug, Zepbound, for treating moderate to severe obstructive sleep apnea (OSA) in ...

IF YOU TAKE a GLP-1 agonist like Ozempic or Zepbound, you can see changes to your waistline and your blood sugar within weeks ...

Studies are limited, but health experts say imbibing on a GLP-1 drug can carry some theoretical risks. Here are 7 things to ...

According to the FDA, the improvement in participants with OSA is likely related to body weight reduction with Zepbound. Side effects of the medication include nausea, diarrhea, vomiting ...

The weight loss drug Zepbound has become the first prescription medication approved to treat obstructive sleep apnea. The Food and Drug Administration on Friday authorized the use of Zepbound ...

The approval is based on two trials of men and women ... side effects and the need for long-term management plans, which are still being studied.” Lilly researchers looked at whether Zepbound ...

21 (UPI) --Zepbound, the new GLP-1 weight-loss drug ... In a new study, researchers examined the health effects people experienced when they returned to still-standing homes after the Marshall ...

(CNN) — The US Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the weight-loss drug Zepbound ... most common side effects were ...